Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-03 Li Dean Y Director Grant or award · Stock Option (Right to Buy) +26,193 26,193
2024-05-30 Marriott Tina President and COO Exercise or conversion 10b5-1 +3,000 $1.06 $3K 538,457
2024-05-30 Marriott Tina President and COO Sale 10b5-1 −3,000 $8.78 $26K 535,457
2024-05-30 Marriott Tina President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −0 482,000
2024-05-28 Borgeson Blake Director Sale 10b5-1 −11,447 $9.17 $105K 7,186,913
2024-05-15 Marriott Tina President and COO Shares withheld for taxes −9,998 $10.01 $100K 533,233
2024-05-15 Mauro David J Chief Medical Officer Shares withheld for taxes −867 $10.01 $9K 243,762
2024-05-15 Gibson Christopher Chief Executive Officer Shares withheld for taxes −26,082 $10.01 $261K 808,738
2024-05-15 Secora Michael Chief Financial Officer Shares withheld for taxes −11,962 $10.01 $120K 1,219,093
2024-05-14 Borgeson Blake Director Sale 10b5-1 −20,054 $10.12 $203K 7,198,360
2024-05-02 Gibson Christopher Chief Executive Officer Sale 10b5-1 −28,704 $8.47 $243K 834,820
2024-05-02 Gibson Christopher Chief Executive Officer Conversion 10b5-1 +21,296 856,116
2024-05-02 Gibson Christopher Chief Executive Officer Sale 10b5-1 −21,296 $8.47 $180K 834,820
2024-05-02 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −21,296 6,426,700
2024-05-01 Gibson Christopher Chief Executive Officer Gift 10b5-1 −25,000 913,524
2024-05-01 Gibson Christopher Chief Executive Officer Sale 10b5-1 −50,000 $7.73 $387K 863,524
2024-04-30 Borgeson Blake Director Sale 10b5-1 −11,447 $7.95 $91K 7,218,414
2024-04-25 Marriott Tina President and COO Exercise or conversion 10b5-1 +3,000 $1.06 $3K 546,231
2024-04-25 Marriott Tina President and COO Sale 10b5-1 −3,000 $7.67 $23K 543,231
2024-04-25 Marriott Tina President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,000 485,000

Page 20 of 41 · 805 trades